Status:
COMPLETED
Hepatitis B Virus Reactivation in COVID-19
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
COVID-19 Pneumonia
Hypoxemia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational cohort study was to evaluate adherence to hepatitis B virus (HBV) screening guidelines in a country characterized by low HBV prevalence and assess the potential reactivat...
Eligibility Criteria
Inclusion
- hospitalized adult patients with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) polymerase chain reaction (PCR) test
- supplemental oxygen
- treated with corticosteroids for COVID-19 pneumonia
Exclusion
- age under 18 years
- hospitalized for medical conditions unrelated to COVID-19
- received corticosteroid therapy for non-COVID-19 reasons
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 8 2022
Estimated Enrollment :
1793 Patients enrolled
Trial Details
Trial ID
NCT07154212
Start Date
November 1 2020
End Date
April 8 2022
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Ljubljana
Ljubljana, Slovenia